Atlas Trials

Treatment Resistant Depression

255 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Treatment Resistant Depression

RecordFirmDate
Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression (SAINT-TRD) (NCT03068715)Stanford University2017-03-20
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (NCT02960763)Washington University School of Medicine2017-02-24
PINS Stimulator System for Patients With Treatment Resistant Depression (NCT02253355)Beijing Pins Medical Co., Ltd2016-12-01
Effects of TBS on 5-HT1A Receptor Binding (NCT02810717)Rupert Lanzenberger2016-12-01
The UTHealth Ketamine Project (NCT02882711)The University of Texas Health Science Center, Houston2016-11-07
Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients (NCT02935595)The University of Texas Health Science Center, Houston2016-10-14
Neurocognitive Features of Patients With Treatment-Resistant Depression (NCT03134066)Massachusetts General Hospital2016-09-01
Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression (NCT03109717)Kathryn O'Connor2016-07-01
D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression (NCT02772211)Sheba Medical Center2016-06-01
Long Term Follow-up of Deep Brain Stimulation for Treatment-Resistant Depression (NCT03360942)Dartmouth-Hitchcock Medical Center2016-04-18
Treatment Resistant Depression and Insomnia in Older Veterans (NCT02971150)VA Pittsburgh Healthcare System2016-04-01
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression (NCT02497287)Janssen Research & Development, LLC2015-09-30
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression (NCT02417064)Janssen Research & Development, LLC2015-08-10
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression (NCT02418585)Janssen Research & Development, LLC2015-08-07
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression (NCT02522377)The Cleveland Clinic2015-08-01
Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression (NCT02360280)VA Office of Research and Development2015-04-01
Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) (NCT01920555)Massachusetts General Hospital2014-12-01
Implementation Trial of Evidence Based Practices for Mood Disorders (NCT02150577)University of Arkansas2014-05-01
Deep Brain Stimulation (DBS) Therapy for Treatment Resistant Depression (NCT02046330)The University of Texas Health Science Center, Houston2013-12-16
Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (NCT01913535)Massachusetts General Hospital2013-09-12
Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy (NCT01935115)University of Saskatchewan2013-09-01
Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S (NCT01984710)Emory University2013-09-01
Focal Electrically Administered Seizure Therapy for the Treatment of Depression (NCT02462551)Ziad Nahas2013-09-01
Low Field Magnetic Stimulation for Treatment Resistant Depression (NCT01944644)Weill Medical College of Cornell University2013-08-01
Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD) (NCT01898429)Paul Holtzheimer2013-07-01
Action of Ketamine in Treatment-Resistant Depression (NCT01945047)University of Ottawa2013-05-01
Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression (NCT01654796)Massachusetts General Hospital2013-04-01
Interpersonal Psychotherapy for Treatment Resistant Depression (NCT01896349)Hospital de Clinicas de Porto Alegre2013-04-01
An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay (NCT01507155)Genomind, LLC2013-04-01
Coupling Repetitive Transcranial Magnetic Stimulation With a Neuronavigation System in Treatment Resistant Depression (NCT01677078)Rennes University Hospital2013-01-21
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression (NCT01687478)Eli Lilly and Company2012-09-01
Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder (NCT01598324)Mclean Hospital2012-07-01
Exercise in Treatment Resistant Depression (TRD): A Feasibility Study (NCT01383811)Milton S. Hershey Medical Center2011-06-01
Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant Depression (NCT01353092)Hillerod Hospital, Denmark2011-04-01
Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression (NCT01246908)CeNeRx BioPharma Inc.2010-11-01
A Study in Relapse Prevention of Treatment-Resistant Depression (NCT00958568)Eli Lilly and Company2009-08-01
A Pilot Study of the Use of Magnetic Seizure Therapy for Depression (NCT00808938)Bayside Health2009-01-01
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients (NCT00789854)AstraZeneca2008-11-01
Ketamine Frequency Treatment for Major Depressive Disorder (NCT00646087)Essentia Health2008-03-01
Epidural Cortical Stimulation for Depression (NCT00565617)Medical University of South Carolina2007-10-01
Berlin Deep Brain Stimulation Depression Study (NCT00531726)Charite University, Berlin, Germany2007-09-01
Deep Brain Stimulation in Treatment Resistant Depression (NCT01435148)North Bristol NHS Trust2006-12-01
Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment (NCT00178854)Vanderbilt University Medical Center2004-05-01
← Previous Next →

Track Treatment Resistant Depression automatically

Every clearance here is in the API, with alerts when new ones post.